We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Are Two Pathways Better Than One? Experts Discuss the Role of Ang-2/VEGF-A Inhibition in Retinal Vascular Disease
Arshad M. Khanani, MD, MA
Karl Csaky, MD, PhD
Christina Y. Weng, MD, MBA, FASRS
Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
Carl Regillo, MD
Jennifer I. Lim, MD, FARVO
GET REAL: A Guide to Evolving Treatment of nAMD and DME Using Real-World Data
Theodore Leng, MD, MS
TED MicroModules: A Sudden Turn in TED Progression
Trisha Cubb, MD, FACE
Audrey Ko, MD
TED MicroModules: The Many Faces of TED in General Eye Care Practices
Lisa M. Nijm, MD, JD
Amy Patel Jain, MD
TED MicroModules: A Curious Case of Thyroid Dysfunction in TED
TED MicroModules: A Multipronged Approach to TED Treatment
TED MicroModules: Journey Through Primary Care, Endocrinology, and Oculoplastics
TED MicroModules: From Thyroid Fix to TED Twist
Extending Treatment Durability With Next-Generation Neovascular AMD Therapies
Durga Borkar, MD, MMCi
Diana Do, MD
Peter K. Kaiser, MD
KOL KNOCKOUT™: Endocrinology Edition – Thyroid Titans Clash to Enhance Outcomes in Thyroid Eye Disease – Round 2
Malini Gupta, MD, ECNU, FACE
Kaniksha Desai, MD, ECNU, FACE
Rokshana R. Thanadar, MD, FACE, FEAA
Melissa Garduno Young, MD, FACE, FACP, ECNU
Improving Outcomes in Patients with RVO: Tailoring Treatment
Carl Danzig, MD
TED MicroModules: An Unusual Case of Inflammatory TED
Jennifer Murdock, MD
Rachel Shlomov, OD
TED MicroModules: A Case of Asymmetric and Quiet TED
KOL Knockout™: Endocrinology Edition – Thyroid Titans Clash to Enhance Outcomes in Thyroid Eye Disease Round 1
Alireza Falahati, MD, FACE
Anupam Kotwal, MD, MSc, FACE, FRCP (Edin)
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education